Mayne Pharma Group Limited (MYX.AX)
Makes and distributes specialty drugs for women's health and skin care globally.
2.64+0.01%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-47.9%
The outlook
Mayne Pharma trades near its 52-week low, with a mixed near-term price trend against its moving averages. Analyst coverage shows an average price target about 75% above the current level, though the stock's recent momentum remains neutral overall.
What’s behind the score
Price trendMixed vs its moving averages
52-week range13% of the way from its 52-week low to high
Price targetAvg target +75% vs current price
Analyst price target
~12-month · 2 analysts4.62average target+74.8% vs now
Now 2.64
Low 3.83High 5.40
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$214.5M
52-wk high
6.50
52-wk low
2.04
50-day avg
2.56
200-day avg
3.04
Trailing P/E
—